Andreas C. Lazaris
- Oncology top 10%
- Cancer-related Molecular Pathways 9
- HER2/EGFR in Cancer Research 6
- Otorhinolaryngology top 10%
-
- Cancer, Hypoxia, and Metabolism 5
- Dermatology top 5%
- Periodontics top 10%
-
- Cell death mechanisms and regulation 5
- RNA modifications and cancer 4
-
- Lung Cancer Treatments and Mutations 4
-
- Cancer Research and Treatments 4
-
- Bladder and Urothelial Cancer Treatments 4
- Co-authors
- Efstratios PatsourisNikolaos KavantzasChristos YapijakisStavros VassiliouAntonis VylliotisL. NakopoulouEleftherios VairaktarisKyriaki Aroni
- Journals
- British Journal of Haematology (2 papers)Medical Oncology (2 papers)Journal of Cancer Research and Clinical Oncology (2 papers)
- Partner nations
- GreeceGermanyUnited Kingdom
In The Last Decade
Andreas C. Lazaris
56 papers receiving 799 citations
Peers
Comparison fields: 5 of 84
- Oncology 321
- Otorhinolaryngology 45
- Cancer Research 151
- Dermatology 79
- Periodontics 30
Countries citing papers authored by Andreas C. Lazaris
This map shows the geographic impact of Andreas C. Lazaris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas C. Lazaris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas C. Lazaris more than expected).
Fields of papers citing papers by Andreas C. Lazaris
This network shows the impact of papers produced by Andreas C. Lazaris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas C. Lazaris. The network helps show where Andreas C. Lazaris may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andreas C. Lazaris, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 3 | |
| 4 | 2022 | 2 | |
| 5 | 2021 | 7 | |
| 6 | 2020 | 25 | |
| 7 | 2020 | 6 | |
| 8 | 2014 | 14 | |
| 9 | 2009 | 18 | |
| 10 | 2008 | 11 | |
| 11 | 2008 | 7 | |
| 12 | 2008 | 23 | |
| 13 | 2007 | 5 | |
| 14 | Abundance and localization of skeletal muscle-related erbB2 may stimulate tumour growth during initial stages of oral oncogenesis. | 2007 | 4 |
| 15 | 2006 | 6 | |
| 16 | 2006 | 11 | |
| 17 | 2005 | 14 | |
| 18 | 2005 | 32 | |
| 19 | 2004 | 63 | |
| 20 | 2003 | 1 |
About Andreas C. Lazaris
Andreas C. Lazaris is a scholar working on Oncology, Cancer Research and Otorhinolaryngology, having authored 61 papers that have together received 824 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (9 papers), HER2/EGFR in Cancer Research (6 papers), Cell death mechanisms and regulation (5 papers), Cancer, Hypoxia, and Metabolism (5 papers), Lung Cancer Treatments and Mutations (4 papers), Cancer Research and Treatments (4 papers), Bladder and Urothelial Cancer Treatments (4 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Oncology (321 citations), Otorhinolaryngology (45 citations) and Cancer Research (151 citations). Andreas C. Lazaris has collaborated with scholars based in Greece, Germany and United Kingdom. Frequent co-authors include Efstratios Patsouris, Nikolaos Kavantzas, Christos Yapijakis, Stavros Vassiliou, Antonis Vylliotis, L. Nakopoulou, Eleftherios Vairaktaris, Kyriaki Aroni, Sofia Spyridonidou and Effie Panayotopoulou. Their work appears in journals such as British Journal of Haematology, Medical Oncology, Journal of Cancer Research and Clinical Oncology, Journal of Cranio-Maxillofacial Surgery and Archives of Gynecology and Obstetrics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.